Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 167.50
-5.00 (-2.90%)
Oct 30, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 45.17 billion as of October 30, 2026. It is the 8,273rd most valuable company in the world and the 239th biggest in Taiwan. Its market cap has decreased by 39.94% in one year.
Market Cap
45.17B
Enterprise Value
97.29B
Revenue
28.49B
Global Rank
Country Rank
#239 Taiwan
PE Ratio
11.78
ChartMarket Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 45.17B, an increase of 391.68%. That is a compound annual growth rate of 13.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 45.17B | -39.30% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 50.41B |
| Center Laboratories | 23.34B |
| Handa Pharmaceuticals | 22.19B |
| TTY Biopharm Company | 19.92B |
| ScinoPharm Taiwan | 15.81B |
| YungShin Global Holding | 15.77B |
| Synmosa Biopharma | 15.64B |
| Grape King Bio | 12.33B |